News

Home-use oxygen for the treatment of cluster headache has not been a coverable benefit for Medicare and Medicaid beneficiaries. This is despite the therapy being a proven safe and effective way to abort a cluster headache attack.

Meet Mia Minen, MD, MPH, FAHS, Chair Special Interest Sections

Meet Andrew D. Hershey, MD, PhD, FAAN, FAHS, Chair Guidelines Committee

Meet Morris Levin, MD, FAHS, AHS Board Member-at-Large

Learn about the diagnosis, symptoms and treatment of migraine specifically for your adolescent patients.

What primary care practitioners should know about nutraceuticals for migraine

American Headache Society (AHS) joined with 85 other medical associations and specialty societies in praise of a renewed Congressional pledge to support physician training.

Meet Rebecca Erwin Wells, MD, MPH, FAHS, AHS Board Member-at-Large

On January 26th, AHS president, Peter Goadsby, MD, PhD, FAHS sent a letter to Centers for Medicare & Medicaid Services (CMS) urging an immediate stop to the implementation of the recently finalized “Most Favored Nation” (MFN) Model.

Kathleen Digre, MD, FAHS, was featured recently in The Lancet Neurology, where she discusses how she fell in love with neurology and her hopes for the field.

We advocate for the Centers for Medicare & Medicaid Services to cover home use oxygen therapy for the acute treatment of cluster headache attacks

Racism is a public health issue and as a scientific healthcare organization and patient advocacy organization we recognize the need for us to take an active role.

In the video, Dr. Robblee explains telemedicine techniques, gives advice on preparing patients for the appointment and explains how to modify common neurological exam techniques to fit the necessary limitations of telemedicine.